Is Carisma Therapeutics (Carm) listed on the NASDAQ?

Carisma Therapeutics, Inc. is currently listed on NASDAQ under CARM. One share of CARM stock can currently be purchased for approximately $2.47. Is Carisma Therapeutics, Inc. listed on the NASDAQ or NYSE? Carisma Therapeutics, Inc. is listed on the NASDAQ as (NASDAQ:CARM). What is Carisma Therapeutics, Inc.'s stock symbol?

Should you buy Carm (Carm) stock in 2022?

In 2022, CARM's revenue was $40.00 million, an increase of 50.69% compared to the previous year's $26.54 million. Losses were -$19.88 million, 5817.9% more than in 2021. According to 3 analysts, the average rating for CARM stock is "Strong Buy." The 12-month stock price forecast is $11.0, which is an increase of 160.05% from the latest price.

What is Carm?

Introducing CaRM. Manage cardiac remote monitoring data, reimbursement and billing with ease and efficiency. Simplify the tedious tasks associated with managing cardiac device data to deliver improved patient experiences while saving time and capturing associated revenue. Simple.

Is Carm trading at a 61% discount?

CARM is trading at a 61% discount. Is it the right time to buy, sell, or hold? Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CARM is a good fit for your portfolio.